A comparison of genomic assays in determining risk of late recurrence and benefit of extended endocrine therapy (EET).
Publication/Presentation Date
5-2017
Volume
35
Issue
15
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Hematology-Medical Oncology Division, Hematology-Medical Oncology Division Fellows and Residents, Fellows and Residents
Document Type
Article
COinS